Combined Misoprostol and Cervical Balloon vs Misoprostol Alone for Induction on the First Day in Primiparas

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorPeking University First Hospital

About this trial

Misoprostol (a prostaglandin E1 analog) is commonly used for cervical ripening and labor induction via vaginal administration. The cervical balloon is another commonly used method that provides mechanical cervical dilation. Both methods are low-cost and widely available. Some meta-analyses have suggested that combined use may shorten the duration of labor, reduce the frequency of tachysystole, and lower NICU admission rates without increasing the risk of cesarean section. However, existing studies are heterogeneous and lack data from Asian populations.

This study is being done to see whether combining two common methods of labor induction-misoprostol (a medicine placed in the vagina) and a cervical balloon (placed in the cervix) on the first day of induction-can shorten the time from the start of induction to delivery in first-time mothers during pregnancy .

Participants will be randomly assigned to one of two groups: one group will receive misoprostol alone (standard care) on the first day of induction, and the other group will receive misoprostol plus a cervical balloon on the first day of induction. The main outcome measured is the time from the start of induction to delivery. The study will also look at safety outcomes, including the rate of cesarean section, maternal complications, and newborn outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 20-45 years at delivery

Singleton pregnancy

Primiparous

Cephalic presentation

Disqualifiers

Multiple pregnancy

Contraindications to vaginal delivery

Mental disorders (depression or anxiety)

Preterm labor (< 37 weeks)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Misoprostol

    Drug

    25 μg misoprostol tablet placed in the posterior vaginal fornix for cervical ripening and labor induction on the first day. May be repeated up to 3-4 times based on uterine contraction response (monitored every 2-4 hours).

  • Misoprostol plus Cervical Balloon

    Device

    A Cervical balloon with 80 mL sterile water inflation placed intracervically for mechanical cervical dilation. The balloon is left in place for up to 12-24 hours or until spontaneous expulsion.

Treatment groups

220 Participants
are divided into 2 treatment groups
Group A: Misoprostol Plus Cervical BalloonExperimental treatment 1 intervention
Group B: Misoprostol AloneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time from initiation of labor induction to delivery

Time in hours from the start of labor induction (placement of first dose of misoprostol or Foley balloon) to vaginal delivery or cesarean section.

Time frame
Time from initiation of induction measures on the first day of induction to delivery (control group: time of first misoprostol placement; intervention group: time of cervical balloon and misoprostol placement).

Secondary outcomes

1

Time from Induction to Amniotomy

Duration from the start of induction (placement of misoprostol or balloon+misoprostol) to the performance of amniotomy, measured in minutes.

Time frame
From start of induction to amniotomy
2

Time from Induction to Spontaneous Membrane Rupture

Duration from the start of induction to spontaneous rupture of fetal membranes, measured in hours.

Time frame
From start of induction to spontaneous rupture
3

Time from Induction to Onset of Labor

Duration from the start of induction to the establishment of regular painful uterine contractions with cervical opening, measured in minutes.

Time frame
From start of induction to onset of labor
4

Duration of Balloon Use

Total time the cervical balloon remains in place (from insertion to removal), measured in minutes.

Time frame
From balloon insertion to removal, assessed during the induction period (up to 24 hours).

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: